BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 7467565)

  • 1. [Glomerulonephritis therapy. Immunosuppression or coagulation inhibitors - a comparison].
    Schmitt E; Sinn W; Lakner V; Ratner M; Tomilina N
    Z Gesamte Inn Med; 1980 Aug; 35(15):Suppl 45-8. PubMed ID: 7467565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of primary glomerulonephritis. Comparative study on the effect of cytostatics-prednisone and cytostatics-anticoagulant-aggregation inhibitor combination].
    Schmitt E; Kröger E; Lakner V; Klinkmann H; Ratner M; Tomilina N
    Z Gesamte Inn Med; 1979 Sep; 34(17):465-71. PubMed ID: 539014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of combined immunosuppressive anticoagulant and antiplatelet therapy of the course of chronic mesangial-proliferative glomerulonephritis.
    Matousovic K; Matl I; Zabka J; Zástava V; Rossmann P; Prát V
    Czech Med; 1985; 8(3):151-7. PubMed ID: 3932033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A clinico-morphological analysis of the efficacy of therapy in chronic glomerulonephritis using prednisone, a cytostatic, an anticoagulant and an antiaggregant].
    Ratner MIa; Fedorova ND
    Urol Nefrol (Mosk); 1996; (2):32-5. PubMed ID: 8677550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined immunosuppressive and anticoagulant treatment in children with glomerulonephritis and declining renal function.
    Savage JM; Postlethwaite RJ; Lendon M; Houston IB; Evans DI
    Int J Pediatr Nephrol; 1982 Sep; 3(3):167-73. PubMed ID: 7141788
    [No Abstract]   [Full Text] [Related]  

  • 6. Are anticoagulants beneficial in the treatment of rapidly progressive glomerulonephritis?
    Cameron JS
    Proc Eur Dial Transplant Assoc; 1973; 10(0):57-90. PubMed ID: 4606240
    [No Abstract]   [Full Text] [Related]  

  • 7. [New results concerning the effectiveness of therapy of chronic glomerulonephritis. Results of cytostatics-anticoagulants-aggregation inhibitors, cystostatics-anticoagulants-aggregation inhibitors-prednisone and cystostatics-prednisone therapy, derived from a retrospective study].
    Sinn W; Ratner M; Tomilina N; Klinkmann H; Nizze H
    Z Urol Nephrol; 1986 Aug; 79(8):449-57. PubMed ID: 3535293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of mesangiocapillary glomerulonephritis in children with combined immunosuppression and anticoagulation.
    Chapman SJ; Cameron JS; Chantler C; Turner D
    Arch Dis Child; 1980 Jun; 55(6):446-51. PubMed ID: 7436483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Special pharmacotherapy of primary glomerulonephritis in the adult].
    Thiele KG
    Dtsch Med Wochenschr; 1975 Sep; 100(36):1803-4. PubMed ID: 1157682
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunosuppressive therapy in primary glomerulonephritis (pros).
    Ponticelli C; Banfi G; Imbasciati E; Tarantino A
    Contrib Nephrol; 1982; (34):33-54. PubMed ID: 6293765
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of primary chronic glomerulonephritis with a triple combination of prednisone, azathioprine and a nitrogen mustard derivative].
    Traver JA; Guajardo DS; Botella J
    Rev Clin Esp; 1975 May; 137(4):321-5. PubMed ID: 1144863
    [No Abstract]   [Full Text] [Related]  

  • 12. Corticosteroid and immunosuppressive treatment in glomerulonephritis. (Literature review).
    Alatas H
    Paediatr Indones; 1974; 14(7-8):135-42. PubMed ID: 4617177
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of the treatment of mesangiocapillary glomerulonephritis].
    Rodríguez JA; Olmos A; Ferrer E; Mauri JM; Capdevilla L; Codina S; Alsina J; Camps J; Piera L
    Rev Clin Esp; 1975 Dec; 139(5):415-22. PubMed ID: 1215585
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapidly progressive glomerulonephritis treated with anticoagulants.
    Arieff AI; Pinggera WF
    Arch Intern Med; 1972 Jan; 129(1):77-84. PubMed ID: 4550298
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of chronic glomerulopathy].
    Orlowski T; Gradowska L; Lao M; Rancewicz Z; Rowinska D
    Z Gesamte Inn Med; 1972 Nov; 27(22):980-3. PubMed ID: 4649659
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anticoagulation and immunosuppression in rapidly progressive glomerulonephritis of poststreptococcal type (author's transl)].
    Kampf D; Höfer W; Misgeld V
    Med Klin; 1978 Mar; 73(11):395-400. PubMed ID: 634203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Indications and limitations of immunosuppressive therapy in chronic glomerulonephritis].
    Ponticelli C; Brancaccio D; Locatelli F; Imbasciati E
    Minerva Nefrol; 1969; 16(3):228-34. PubMed ID: 5356052
    [No Abstract]   [Full Text] [Related]  

  • 18. [Further study of the indications for combination cytostatic-anticoagulant-antiaggregation-corticosteroid therapy of chronic glomerulonephritis].
    Ratner MIa; Tomilina NA; Biriukova LS; Monchakovskiĭ SF
    Ter Arkh; 1985; 57(6):69-74. PubMed ID: 4071418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of immunosuppressive therapy of chronic glomerulonephritis in 400 patients].
    Müller V; Natusch R; Göbel U; Laske HR; Sperschneider H; Pap I; Sinn W; Koall W; Achenbach H; Tredt HJ
    Z Urol Nephrol; 1985 Jan; 78(1):39-55. PubMed ID: 3976309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical treatment of glomerular diseases.
    Simon NM; Rosenberg MJ
    Med Clin North Am; 1978 Nov; 62(6):1157-81. PubMed ID: 153991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.